Aethlon Medical Files 8-K with Financial Updates
Ticker: AEMD · Form: 8-K · Filed: Aug 21, 2025 · CIK: 882291
| Field | Detail |
|---|---|
| Company | Aethlon Medical Inc (AEMD) |
| Form Type | 8-K |
| Filed Date | Aug 21, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-reporting, regulation-fd
Related Tickers: AETH
TL;DR
AETH filed an 8-K on 8/21/25 - check for financial updates and disclosures.
AI Summary
Aethlon Medical, Inc. filed an 8-K on August 21, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the company's current report status and provides information regarding its corporate structure and financial reporting.
Why It Matters
This filing provides crucial updates on Aethlon Medical's financial status and regulatory disclosures, which are important for investors to assess the company's performance and compliance.
Risk Assessment
Risk Level: medium — 8-K filings can contain significant corporate or financial news that may impact stock price, requiring careful review.
Key Players & Entities
- Aethlon Medical, Inc. (company) — Registrant
- August 21, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- 11555 Sorrento Valley Road, Suite 203 (address) — Principal executive offices
- San Diego, California (location) — City and State of principal executive offices
- 619-941-0360 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for Aethlon Medical, Inc.?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits as of August 21, 2025.
What is Aethlon Medical, Inc.'s state of incorporation?
Aethlon Medical, Inc. is incorporated in Nevada.
What is the address of Aethlon Medical, Inc.'s principal executive offices?
The address of Aethlon Medical, Inc.'s principal executive offices is 11555 Sorrento Valley Road, Suite 203, San Diego, California 92121.
What is the telephone number for Aethlon Medical, Inc.?
The telephone number for Aethlon Medical, Inc. is (619) 941-0360.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on August 21, 2025.
Filing Stats: 609 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2025-08-21 14:34:05
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share AEMD The Nasdaq
Filing Documents
- aemd_8k.htm (8-K) — 28KB
- aemd_ex9901.htm (EX-99.1) — 35KB
- image_040.jpg (GRAPHIC) — 163KB
- image_041.jpg (GRAPHIC) — 541KB
- image_042.jpg (GRAPHIC) — 243KB
- image_043.jpg (GRAPHIC) — 224KB
- image_044.jpg (GRAPHIC) — 291KB
- image_045.jpg (GRAPHIC) — 197KB
- image_046.jpg (GRAPHIC) — 70KB
- image_047.jpg (GRAPHIC) — 302KB
- image_048.jpg (GRAPHIC) — 250KB
- image_049.jpg (GRAPHIC) — 325KB
- image_050.jpg (GRAPHIC) — 261KB
- image_051.jpg (GRAPHIC) — 319KB
- image_052.jpg (GRAPHIC) — 69KB
- image_053.jpg (GRAPHIC) — 355KB
- image_054.jpg (GRAPHIC) — 165KB
- image_055.jpg (GRAPHIC) — 309KB
- image_056.jpg (GRAPHIC) — 226KB
- image_057.jpg (GRAPHIC) — 267KB
- image_058.jpg (GRAPHIC) — 369KB
- image_059.jpg (GRAPHIC) — 264KB
- image_060.jpg (GRAPHIC) — 174KB
- 0001683168-25-006360.txt ( ) — 7652KB
- aemd-20250821.xsd (EX-101.SCH) — 3KB
- aemd-20250821_lab.xml (EX-101.LAB) — 33KB
- aemd-20250821_pre.xml (EX-101.PRE) — 22KB
- aemd_8k_htm.xml (XML) — 4KB
01 Regulation FD Disclosures
Item 7.01 Regulation FD Disclosures. On August 20, 2025, Aethlon Medical, Inc. (the "Company") made available an updated corporate presentation (the "Presentation") that may be used by the Company in connection with presentations at conferences and investor meetings. The Presentation can be found on the Company's website, www.aethlonmedical.com. The Presentation is furnished as Exhibit 99.1 hereto. The information in the Presentation is being furnished, not filed, pursuant to this Item 7.01. Accordingly, the information in the Presentation will not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as expressly set forth by specific reference in such a filing. The furnishing of the information in this Current Report on Form 8-K with respect to the Presentation is not intended to, and does not, constitute a determination or admission by the Company that the information in this Current Report on Form 8-K with respect to the Presentation is material or complete, or that investors should consider this information before making an investment decision with respect to any security of the Company.
01 Financial
Item 9.01 Financial (d) Exhibits Exhibit Number Description 99.1 Presentation Materials 104 Cover Page Interactive Data File (embedded within the inline XBRL Document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 21, 2025 Aethlon Medical, Inc. By: /s/ James B. Frakes Name: Title: James B. Frakes Chief Executive Officer and Chief Financial Officer 3